Adverse effects of lithium treatment and safety measures;Litiumbehandlingens biverkningar och säkerhetsrutiner

Lakartidningen

Volumn 101, Issue 21-22, 2004, Pages 1902-1908

  Bendz, Hans ^a,c   Aurell, Mattias ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Psykiatriska Oppenvardsmottagningen   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VASOPRESSIN;

GLOMERULUS; HUMAN; INTOXICATION; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; REVIEW; RISK ASSESSMENT; SAFETY; TREATMENT OUTCOME; BIPOLAR DISORDER; DRUG EFFECT; KIDNEY FUNCTION TEST; NEPHRON; PARATHYROID GLAND; RISK FACTOR; THYROID FUNCTION TEST;

BIPOLAR DISORDER; HUMANS; KIDNEY FUNCTION TESTS; LITHIUM; NEPHRONS; PARATHYROID GLANDS; RISK FACTORS; SAFETY; THYROID FUNCTION TESTS;

EID: 3042814141     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bendz H, Aurell M, Balldin J, Mathé AA, Sjödin I. Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 11:457-60.
2. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;2:349-52.
3. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;ii:326-30.
4. Bauer MS, Mitchner L. What is a »mood« stabilizer? An evidence-based response. Am J Psychiatry 2004;161:3-18.
5. Lambert PA, Venaud G. Étude comparative du valpromide versus lithium dans la prophylaxie des troubles thymiques. Nervure 1992;5:57-65.
6. Bowden CL. Valproate. Bipolar Disord 2003;5:189-202.
7. Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin S, Schmidt S, Engel RR, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Disord 1997;43:151-61.
8. Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigin. A review of its use in bipolar disorder. Drugs 2003;63:2029-50.
9. Anonym. Dåligt känd biverkan vid operation orsakade kvinnas död. Läkartidningen 1995;92:3924.
10. Hansen HE, Amdisen A. Lithium intoxication. Quarterly Journal of Medicine New Series 1978;XLVII(186):123-44.
11. Hestbech J, Hansen HE, Amdisen A, Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int 1977;12: 205-13.
12. Aurell M, Svalander C, Wallin L, Alling C. Renal function and biopsy findings in patients on long-term lithium-treatment. Kidney Int 1981;20:663-70.
13. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD. Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000;11:1439-48.
14. Kushner JP, Wartofsky L. Lithium-thyroid interactions. An overview. In: Johnson FN, editor. Lithium and the endocrine system. Basel: S Karger AG; 1988. p. 74-98.
15. Barclay ML, Brownlie BE, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol 1994;40:759-64.
16. Bendz H, Sjödin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy - a cross-sectional study and the effect of lithium withdrawal. J Intern Med 1996;240:357-65.
17. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146-50.
18. Pachet AK, Wisniewski AM. The effects of lithium on cognition: an updated review. Psychopharmacology 2003;170:225-34.
19. Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF, et al. Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry 1996;153: 1301-7.
20. Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002;159:1155-9.